The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kumar Neil since 2018.
This trader's CIK number is 1742485.
At the time of last reporting, Kumar Neil was the Chief Executive Officer of Bridgebio Pharma, Inc.. (stock ticker symbol BBIO).
Also see all insider trading activities at Bridgebio Pharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | EIDX | 1,986,201 | $55,006,015 | 0 | $0 | 0 | $0 |
| 2018 | EIDX | 1,000,000 | $17,000,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | BBIO | 0 | $0 | 1,143,855 | $42,588,044 | 184,932 | $0 |
| 2024 | BBIO | 0 | $0 | 54,778 | $1,296,375 | 273,990 | $0 |
| 2023 | BBIO | 0 | $0 | 799,454 | $11,390,938 | 375,454 | $0 |
| 2022 | BBIO | 0 | $0 | 234,640 | $325,616 | 213,640 | $0 |
| 2021 | BBIO | 0 | $0 | 0 | $0 | 27,699 | $0 |
| 2020 | BBIO | 0 | $0 | 920,000 | $28,496,130 | 10,258 | $0 |
| 2019 | BBIO | 0 | $0 | 0 | $0 | 8,952,428 | $0 |
1. Eidos Therapeutics, Inc. (EIDX)
2. Bridgebio Pharma, Inc. (BBIO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-07-03 | EIDX | Buy | 882,353 | 29.90 | 26,383,237 |
| 2019-05-24 | EIDX | Buy | 1,103,848 | 25.93 | 28,622,778 |
| 2018-06-22 | EIDX | Buy | 1,000,000 | 17.00 | 17,000,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-20 | BBIO | Sale | 26,156 | 49.03 | 1,282,454 |
| 2025-08-16 | BBIO | Option Ex | 64,697 | .00 | 0 |
| 2025-08-07 | BBIO | Sale | 40,000 | 45.37 | 1,814,600 |
| 2025-08-08 | BBIO | Sale | 40,000 | 46.30 | 1,851,800 |
| 2025-07-01 | BBIO | Sale | 40,000 | 42.70 | 1,707,840 |
| 2025-07-02 | BBIO | Sale | 40,000 | 42.73 | 1,709,040 |
| 2025-05-19 | BBIO | Sale | 26,156 | 33.53 | 877,141 |
| 2025-05-20 | BBIO | Sale | 75,000 | 33.40 | 2,505,000 |
| 2025-05-16 | BBIO | Option Ex | 64,696 | .00 | 0 |
| 2025-04-22 | BBIO | Sale | 75,000 | 34.11 | 2,558,025 |
| 2025-03-25 | BBIO | Sale | 75,000 | 36.87 | 2,764,950 |
| 2025-02-25 | BBIO | Sale | 75,000 | 33.58 | 2,518,125 |
| 2025-02-16 | BBIO | Option Ex | 55,539 | .00 | 0 |
| 2025-02-19 | BBIO | Sale | 31,543 | 36.35 | 1,146,588 |
| 2025-01-29 | BBIO | Sale | 273,068 | 36.58 | 9,989,100 |
| 2025-01-28 | BBIO | Sale | 326,932 | 36.29 | 11,863,381 |
| 2024-11-19 | BBIO | Sale | 27,389 | 22.57 | 618,279 |
| 2024-11-16 | BBIO | Option Ex | 55,537 | .00 | 0 |
| 2024-08-16 | BBIO | Option Ex | 55,537 | .00 | 0 |
| 2024-08-19 | BBIO | Sale | 27,389 | 24.76 | 678,096 |
| 2024-05-16 | BBIO | Option Ex | 60,667 | .00 | 0 |
| 2024-02-16 | BBIO | Option Ex | 102,249 | .00 | 0 |
| 2023-11-17 | BBIO | Sale | 51,552 | 29.32 | 1,511,659 |
| 2023-11-16 | BBIO | Option Ex | 102,249 | .00 | 0 |
| 2023-08-16 | BBIO | Option Ex | 102,250 | .00 | 0 |
| 2023-08-17 | BBIO | Sale | 51,552 | 28.59 | 1,473,768 |
| 2023-05-16 | BBIO | Option Ex | 102,249 | .00 | 0 |
| 2023-05-17 | BBIO | Sale | 51,552 | 14.01 | 722,243 |
| 2023-05-03 | BBIO | Sale | 120,000 | 14.18 | 1,701,720 |
| 2023-04-05 | BBIO | Sale | 120,000 | 15.46 | 1,855,680 |
| 2023-03-03 | BBIO | Sale | 120,000 | 10.96 | 1,315,200 |
| 2023-02-16 | BBIO | Option Ex | 68,706 | .00 | 0 |
| 2023-02-17 | BBIO | Sale | 44,798 | 12.70 | 569,068 |
| 2023-02-03 | BBIO | Sale | 120,000 | 11.01 | 1,320,720 |
| 2023-01-05 | BBIO | Sale | 120,000 | 7.67 | 920,880 |
| 2022-12-21 | BBIO | Sale | 200,000 | .00 | 0 |
| 2022-11-17 | BBIO | Sale | 34,640 | 9.40 | 325,616 |
| 2022-11-16 | BBIO | Option Ex | 68,706 | .00 | 0 |
| 2022-08-16 | BBIO | Option Ex | 68,705 | .00 | 0 |
| 2022-05-16 | BBIO | Option Ex | 68,705 | .00 | 0 |
| 2022-02-16 | BBIO | Option Ex | 7,524 | .00 | 0 |
| 2021-11-16 | BBIO | Option Ex | 7,523 | .00 | 0 |
| 2021-08-16 | BBIO | Option Ex | 7,523 | .00 | 0 |
| 2021-05-16 | BBIO | Option Ex | 7,524 | .00 | 0 |
| 2021-02-16 | BBIO | Option Ex | 5,129 | .00 | 0 |
| 2020-11-16 | BBIO | Option Ex | 5,129 | .00 | 0 |
| 2020-08-16 | BBIO | Option Ex | 5,129 | .00 | 0 |
| 2020-08-03 | BBIO | Sale | 66,057 | 27.68 | 1,828,193 |
| 2020-08-04 | BBIO | Sale | 13,943 | 27.03 | 376,893 |
| 2020-07-01 | BBIO | Sale | 87,025 | 31.57 | 2,747,466 |
| 2020-07-02 | BBIO | Sale | 56,445 | 30.23 | 1,706,050 |
| 2020-06-08 | BBIO | Sale | 10,600 | 30.01 | 318,127 |
| 2020-06-03 | BBIO | Sale | 5,930 | 30.05 | 178,172 |
| 2020-06-01 | BBIO | Sale | 80,000 | 29.42 | 2,353,440 |
| 2020-05-05 | BBIO | Sale | 79,600 | 31.05 | 2,471,341 |
| 2020-05-01 | BBIO | Sale | 40,720 | 29.42 | 1,198,104 |
| 2020-05-04 | BBIO | Sale | 39,680 | 29.45 | 1,168,536 |
| 2020-04-07 | BBIO | Sale | 1,805 | 25.48 | 45,982 |
| 2020-04-03 | BBIO | Sale | 300 | 25.09 | 7,528 |
| 2020-04-01 | BBIO | Sale | 62,117 | 26.89 | 1,670,388 |
| 2020-04-02 | BBIO | Sale | 15,778 | 25.04 | 395,096 |
| 2020-03-02 | BBIO | Sale | 99,953 | 32.58 | 3,256,568 |
| 2020-03-03 | BBIO | Sale | 20,047 | 32.53 | 652,088 |
| 2020-02-05 | BBIO | Sale | 30,893 | 34.88 | 1,077,393 |
| 2020-02-03 | BBIO | Sale | 34,156 | 35.06 | 1,197,406 |
| 2020-02-04 | BBIO | Sale | 54,951 | 34.55 | 1,898,392 |
| 2020-01-02 | BBIO | Sale | 36,061 | 33.83 | 1,219,943 |
| 2020-01-03 | BBIO | Sale | 83,939 | 32.51 | 2,729,024 |
| 2019-07-01 | BBIO | Option Ex | 8,952,428 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kumar Neil (Chief Executive Officer of Bridgebio Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.